에 대한 최신 뉴스 BioAtla (NASDAQ:BCAB) 주식

BioAtla

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

Asia

Equities

News

Global

Markets

ACIC

AMZN

BABA

BCAB

BIDU

FOUR

GOOG

GOOGL

OLPX

REAL

2008년 금융 위기 이전 주택 시장에 대한 선견지명 있는 투자로 유명한 유명 투자자 마이클 버리(Michael Burry)는 2024년 2분기에 자신의 헤지 펀드 포트폴리오에 큰 변화를 주었다.

&#39;빅쇼트&#39; 명성의 마이클 버리, 중국에 큰 투자하고 알리바바를 최대 보유 주식으로 공개

BioAtla Inc

Economist Mohamed El-Erian highlighted the risks of an economic slowdown as Federal Reserve Chairman Jerome Powell reiterated that the economy was growing at a &#8220;solid pace&#8221; during his Friday address at the University of Chicago.
What Happened: During a podcast with Forward Guidance, the chief economic advisor at Allianz, El-Erian underscored &#8220;two disturbing data&#8221; sets on the stagflation side.
This included a fall in February&#8217;s ISM Manufacturing New Orders Index, which contracted to 48.6% after expanding for three months, indicating a weakening demand and a decline in new orders compared to the previous month.
The other data set highlighted by El-Erian included February&#8217;s job report, wherein nonfarm payrolls increased by 151,000 and the unemployment rate rose to 4.1%, the highest in 3.5 years, thus inducing uncertainty in the labour market. However, &#8220;one qualification is the slip in labor force participation,&#8221; from 62.6% to 62.4%, according to him.
&#8220;So the concern that we all have, is that while growth is slowing down, companies will feel that they need to pass on the higher costs into higher prices, of course that&#8217;s why tariffs play a major role because people are worried that it won&#8217;t be a once and for all effect, it may be a repeated effect, so there&#8217;s a price level and then there&#8217;s an inflation effect,&#8221; he said.
Economic slowdown was &#8220;the talk of the town,&#8221; El-Erian said while highlighting lower oil prices, negative stock futures, lower yields, and a weaker dollar on Monday.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The possibility of lower US economic growth is now the talk of the town, amplified by this weekend's remarks from high-level officials. As you would expect, the market impact so far this early morning in Asian trading includes lower oil prices (with Brent again joining WTI below… <a href="https://t.co/egyftI2GpR">pic.twitter.com/egyftI2GpR</a>
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1898950253325279263?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, President Donald Trump did not rule out a recession this year, acknowledging potential short-term turbulence from his economic agenda but expressing confidence in future prosperity. In a Fox News interview, he said, "I hate to predict things like that" and called the changes "very big."
See Also: <a href="https://www.benzinga.com/government/regulations/25/03/44160833/us-dollar-weakness-a-symptom-not-cause-argues-expert-as-economist-hails-devaluation-to-restore-global-growth">US Dollar Weakness A &#8216;Symptom Not Cause,&#8217; Argues Expert As Economist Hails Devaluation To &#8216;Restore Global Growth&#8217;</a>
Why It Matters: Despite the looming uncertainties and the difficulty of businesses to chart their way forward, Fed Chair Powell <a href="https://www.federalreserve.gov/newsevents/speech/powell20250307a.htm">said</a>, &#8220;The U.S. economy continues to be in a good place.&#8221;
He reaffirmed that the labor market is solid, and inflation has moved closer to the 2% longer-run goal. &#8220;At the Federal Reserve, we are intently focused on the dual-mandate goals given to us by Congress: maximum employment and stable prices,&#8221; Powell said.
Outlining the future course of action, he said that if inflation doesn&#8217;t fall to the 2% goal, the Fed will maintain policy restraint for longer and if the labor market weakens, the Fed will ease the policy accordingly.
Talking about the rate cuts, El-Erian added that he sees one cut and not three cuts in 2025 because of the persistent inflation and how the Fed is unlikely to &#8220;look through&#8221; that issue, the way they did in 2021.
Price Action: Futures of the Dow Jones slipped to 0.38%, whereas S&amp;P 500 and Nasdaq 100 declined by 0.49% and 0.61% respectively. Crude Oil WTI Futures dropped 0.51% to $66.7, the dollar index spot was down to the 103.816 level and the 10-year Treasury bonds yielded 4.29% as of 2:18 a.m., EDT.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, advanced on Friday. SPY gained 0.56% to $575.92, and QQQ was up 0.74% to $491.79, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44159401/rigetti-claims-leadership-in-quantum-computing-race-aims-to-scale-to-100-qubits-as-it-looks-to-catch-up-with-ibm-google">Rigetti Asserts &#8216;Leadership&#8217; In Quantum Computing Race, Aims To Scale To 100 Qubits As It Looks To Catch Up With IBM, Google</a></li>
</ul>
Photo courtesy: Federal Reserve

Government

Market Summary

Economics

Federal Reserve

US Economic Slowdown 'Talk Of The Town,' Says Economist Mohamed El-Erian As Fed Chair Powell Reaffirms Growth At 'Solid Pace'

<ul>
<li>Low disease activity was observed after a mean duration of 80 consecutive days off-treatment following success with VTAMA cream, with a mean weekly Peak Pruritus Numerical Rating Scale (PP-NRS) score of 2.9 at the end of the treatment-free interval</li>
<li>Data presented as late breaker at 2025 American Academy of Dermatology (AAD) Annual Meeting</li>
</ul>

Reported Saturday, Organon's VTAMA Phase 3 Data Shows 84% Of Patients Maintained Mild Disease After 80-Day Off-Treatment Interval In Adults And Children 2+

<ul>
<li>Significantly more patients treated with Sotyktu achieved ACR and PASI response rates and had greater improvements in patient-reported quality of life compared with placebo at Week 16</li>
<li>Sotyktu was well-tolerated in comparison with placebo and apremilast, demonstrating safety consistent with its established clinical profile</li>
</ul>

Reported Saturday, Bristol Myers Squibb Presents Late-Breaking Phase 3 Data Showing Sotyktu Superior To Placebo In Psoriatic Arthritis

<ul>
<li>Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study</li>
<li>Topline results from Phase 3 ICONIC-ADVANCE 1&amp;2studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe PsO</li>
<li>Results pave the way to initiate the first-ever head-to-head study (ICONIC-ASCEND) seeking to demonstrate the superiority of a pill versus injectable biologic in moderate-to-severe PsO</li>
</ul>

PTGX

Reported Saturday, Protagonist Reports Icotrokinra Achieved IGA 0/1 In 74% Of Patients At Week 24 With Favorable Safety Profile

Four Canadian stores of&nbsp;Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) have been suspected of exploiting the country&#8217;s EV rebate program. The stores are said to have sold an average of 30&nbsp;cars per hour over three days, claiming&nbsp;over 50% of the&nbsp;remaining rebate funds.
What Happened: Four Tesla stores in Canada managed to sell an average of 30 cars per hour, amounting to 120 cars per hour across all four locations, as <a href="https://www.thestar.com/news/canada/tesla-gamed-the-system-canadian-auto-dealers-stiffed-millions-when-u-s-giant-rushed-to/article_6d1025c6-fa0a-11ef-b780-a73277202cb2.html">reported </a>by the Toronto Star on Friday. 
This sales boom lasted for three consecutive days, even during hours when the stores were supposedly closed. Reportedly, a total of 8,653 cars were sold during the final 72 hours of the EV rebate program, also known as the iZEV Program.
Consequently, the Elon Musk-led company applied&nbsp;for C$43.1 million ($30 million) in&nbsp;rebates, which is over&nbsp;half of the remaining C$71.8&nbsp;million ($50 million) allocated for EV&nbsp;rebates.
The iZEV rebate program provided incentives ranging from C$2,500 ($1740.29) to C$5,000 ($3480.57) for purchasing electric vehicles and plug-in hybrids. Dealerships applied the rebate directly to the purchase price, anticipating reimbursement from the government.
Tesla did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment.
As a result of the incident, the rival brands haven&#8217;t been able to access the EV credits as Tesla claimed more than half of them. The Canadian Automobile Dealers Association (CADA), has received rebate claims for 2,295 electric vehicles from 226 dealers who are yet to receive the reimbursement, resulting in a collective shortfall of C$10 million.
CADA&#8217;s spokesperson, Huw Williams, told the Toronto Star, "Somehow, Tesla gamed the system. What we can't figure out is how this could have happened without setting off alarm bells."
Notably, Transport Canada, the body which oversees the iZEV rebate program, has not clarified whether any wrongdoing took place. It also stated that there is no restriction preventing Tesla from submitting rebate paperwork in bulk after delivering sold cars.
SEE ALSO: <a href="https://www.benzinga.com/news/25/03/44211240/warren-buffett-on-debt-and-donald-trumps-money-moves-trump-never-went-right">Warren Buffett on Debt and Donald Trump&#8217;s Money Moves: Trump &#8216;Never Went Right&#8217;</a>
Why It Matters: Tesla has been struggling in Canada, wherein thousands of Canadians have even signed a petition for revoking Musk&#8217;s Canadian citizenship. According to&nbsp;data from shop4tesla.com, the EV maker&#8217;s sales in Canada have dropped by approximately 70% between December 2024 and January 2025.
This surge in sales comes on the heels of Tesla&#8217;s recent offer of lifetime free supercharging for new Foundation Series Cybertruck purchases in Canada. Tesla <a href="https://www.benzinga.com/tech/25/03/44160193/tesla-offers-lifetime-free-supercharging-on-foundation-series-cybertruck-purchases-in-canada-mexico">announced this offer </a>to make the expensive truck more appealing to customers. The offer, valid for orders placed on or after March 5, lasts for the duration of the customer's ownership of the vehicle and is non-transferable.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/25/03/44212993/palantir-ceo-alex-karp-meets-hyundai-vice-chair-to-enhance-ai-shipyard-defense-collaboration-amid-trumps-call-for-us-shipbuilding-revival">Palantir CEO Alex Karp Meets Hyundai Vice Chair to Enhance AI Shipyard, Defense Collaboration Amid Trump&#8217;s Call for US Shipbuilding Revival</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

TSLA

Tesla Suspected Of EV Rebate Manipulation In Canada Amid Sudden Sales Surge Before Deadline: 'Tesla Gamed The System', Says Industry Body

<ul>
<li>Results presented in AAD late-breaker demonstrate bempikibart's encouraging improvement on SALT reduction at week 24 and continued effects after dosing cessation in patients with severe and very severe alopecia areata (AA) --</li>
<li>Durable, ongoing responses in multiple patients through week 36 follow-up period and beyond to week 55, despite only 24 weeks of dosing, suggestive of potential for remittive effect; multiple inbound patient requests to re-initiate dosing --</li>
<li>In the Phase 2a clinical trial, bempikibart was observed to be safe and well-tolerated, with PK supporting subcutaneous dosing and receptor occupancy data demonstrating desired target engagement; clinical biomarkers showed changes in Th2 biomarkers, and expected on-mechanism changes in T-cells, indicative of potent IL-7 and TSLP inhibition --</li>
<li>Bempikibart development program remains on track with open-label extension study to initiate in 1H'25; SIGNAL-AA Part B remains on track for initiation of dosing in 1H'25, with topline data expected in 1H'26 --</li>
</ul>

QTTB

Reported Saturday, Q32 Bio Presents Phase 2a Data Showing Bempikibart Induces Sustained Hair Regrowth Post-Treatment In Severe Alopecia Areata

<ul>
<li>Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg</li>
<li>Patients treated with&nbsp;baricitinib 4 mg saw significant regrowth of eyebrows and eyelashes at Week 36 compared to placebo</li>
<li>Positive data underscore Lilly's continued expansion across dermatologic conditions, with treatments that can improve outcomes for patients with the greatest need</li>
</ul>

INCY

Reported Saturday, Lilly And Incyte Present Late-Breaking Phase 3 Data Showing Baricitinib Significantly Improves Scalp, Eyebrow, And Eyelash Regrowth In Teens With AA

Macro Economic Events

Econ #s

Germany Trade Balance For January 16.0B Vs. 21.0B Est.; 20.7B Prior

Germany Industrial Production (MoM) For January 2.0% Vs. 1.6% Est.; -2.4% Prior

<ul>
<li>Tour 2025 Presented by Snapdragon, will see Manchester United return to the US for the third consecutive year, joining Premier League Summer Series for the first time</li>
<li>The round-robin series features three fixtures, with United set to face West Ham in New Jersey (26 July), AFC Bournemouth in Chicago (30 July) and Everton in Atlanta (3 August)</li>
</ul>

MANU

Reported Sunday, Manchester United To Play In Premier League Summer Series For First Time As Part Of Tour 2025 Presented By Snapdragon

CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial&nbsp;to primarily enroll women using the two most widely used global TAVR devices

Reported Sunday, Medtronic Evolut TAVR Demonstrates Superior Durability And Valve Function In Small Annulus Patients, SMART Trial Shows

A subsidiary of Xpeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/XPNGF#OTC">XPNGF</a>), a Chinese electric vehicle maker and Tesla Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rival, plans to become the world&#8217;s first mass producer of <a href="https://in.benzinga.com/insights/options/25/03/44111960/xpeng-options-trading-a-deep-dive-into-market-sentiment">flying cars by 2026</a>.
What Happened: Xpeng Aeroht&#8217;s &#8220;land aircraft carrier&#8221; — a modular vehicle featuring a passenger drone that unfolds from a six-wheeled van — completed its first public flight at the November Zhuhai Airshow and has reportedly secured approximately 3,000 intended orders, <a href="https://www.straitstimes.com/asia/mass-production-of-flying-cars-in-sight-amid-chinas-low-altitude-economy-push">reported</a> The Straits Times.
&#8220;In 2026, Xpeng plans to mass produce, for the first time, our modular flying car,&#8221; Xpeng Chairman and CEO He Xiaopeng said on Friday. The company broke ground in October on a factory designed to produce 10,000 flying cars annually when completed in the first quarter of 2026.
Priced at no more than 2 million yuan ($275,000), the vehicle accommodates four passengers in the car portion and two in the detachable drone. Initial applications will likely focus on tourism and short-haul rescue missions rather than everyday transportation.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/equities/25/03/44212386/stock-futures-drop-as-reverse-trump-trade-takes-holdpeter-schiff-says-market-shift-long-overdue-and-will-likely-continue-for-a-decade" target="_blank" rel="noreferrer noopener">Stock Futures Drop As ‘Reverse Trump Trade' Takes Hold—Peter Schiff Says Market Shift ‘Long Overdue' And Will Likely Continue For A Decade</a>
Why It Matters: China&#8217;s government has prioritized the &#8220;low-altitude economy&#8221; — economic activity below 1,000 meters — labeling it a &#8220;new growth engine&#8221; in its 2024 annual work report. The sector, projected to reach one trillion yuan ($138 billion) by 2025, encompasses drone deliveries, <a href="https://www.benzinga.com/news/24/10/41551820/flying-taxis-are-almost-here-joby-archer-aviation-applaud-new-faa-regulations-for-evtol-aircraft">air shuttles, and flying taxis</a>.
Regulatory hurdles remain the primary challenge. He Xiaopeng cited concerns about vehicle certification, takeoff regulations, and pilot licensing requirements. &#8220;Right now, I see many problems,&#8221; he acknowledged.
Xpeng&#8217;s ADR stock on NYSE rose 6.16% to $23.60 in Friday&#8217;s trading, though analysts maintain an <a href="https://www.benzinga.com/quote/XPEV/analyst-ratings">average price target</a> of $17.44, suggesting a potential 37.04% downside ahead of the company&#8217;s fourth-quarter earnings report due Mar. 18.
<figure class="wp-block-image aligncenter size-full is-resized"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10020824/Screenshot-2025-03-10-at-11.35.56%E2%80%AFAM.png" alt="" class="wp-image-815913" style="width:694px;height:auto" /></figure>
Price Action: Xpeng traded at 88.85 HKD ($11.43) on the Hong Kong Exchange as of Monday at 1:21 PM local time, down 1.28% for the day.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44212672/jamie-dimon-cashed-out-234-million-in-jpmorgan-stock-warren-buffett-stockpiled-334-billion-in-cash-weeks-later-markets-crashed-coincidence" target="_blank" rel="noreferrer noopener">Jamie Dimon Cashed Out $234 Million In JPMorgan Stock, Warren Buffett Stockpiled $334 Billion In Cash — Weeks Later, Markets Crashed. Coincidence?</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

XPEV

XPNGF

Tesla Rival XPeng Aims To Mass-Produce Flying Cars By 2026, But Regulators May Ground Takeoff

<ul>
<li>Authorized share increase approval supports the FX strategy and continued deliveries of the FF 91 2.0.</li>
<li>Company stock ticker to officially change to "FFAI" starting March 10, 2025.</li>
</ul>

FFIE

Reported Earlier, Faraday Future Gains Shareholder Backing To Raise Capital, Issue Shares For Operations, And Accelerate FX Project

MEOH

Reported Earlier, Methanex Geismar 3 Plant Outage To Impact Q2 Sales, Repair Costs Not Expected To Be Material

BTDR

Reported Earlier, Bitdeer Completes SEAL03 Chip Testing, Achieves 9.7J/TH Power Efficiency Ahead Of SEALMINER A3 Launch

<ul>
<li>Will add UNLOXCYT&#x2122; (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise</li>
<li>Will leverage Sun Pharma's global presence to accelerate patient access to UNLOXCYT&#x2122; (cosibelimab-ipdl)</li>
<li>Upfront cash payment of $4.10 per share of common stock, representing aggregate upfront consideration of up to $355 million Stockholders will also receive a contingent value right for up to $0.70 per share on achievement of a milestone</li>
</ul>
&nbsp;

CKPT

Reported Earlier, Sun Pharma To Acquire Checkpoint Therapeutics In $355M Deal, Adding FDA-Approved UNLOXCYT For Advanced cSCC To Onco-Derm Portfolio

End-to-End Virtual Prototyping Workflows Enable Faster Software Development and Time to Market for Automotive, HPC and IoT System

SNPS

Synopsys Launches Virtualizer Native Execution On Arm To Accelerate SDV And Edge Software Development

Joint Solution to Drive Adoption of "Shift-Left" Software Development Methodologies with the Integration of Synopsys' Electronics Digital Twin Capabilities and Vector's Software Factory

Vector And Synopsys Partner To Advance Shift-Left With Cloud-Ready Software Factory Tools

Key Highlights for February 2025:
<ul>
<li>Bitcoin Production: Mined 89 BTC, bringing HIVE's HODL portfolio to 2,620 BTC, valued at $220 million as of February 28, 2025, based on a BTC closing price of approximately $84,000.</li>
<li>HODL Update: The Company's Bitcoin holdings have increased by 23% year-over-year. However, on a month-over-month basis, BTC holdings saw a decline as HIVE strategically sold a portion of its BTC to invest in capital assets, including Bitfarms' 200 megawatt ("MW") hydro-powered Bitcoin mining assets in Paraguay.</li>
<li>Mining Capacity: Maintained an average mining capacity of 5.6 Exahash per Second ("EH/s") with fleet efficiency at 20.9 Joules per Terahash ("J/TH"). HIVE achieved a peak BTC-only hashrate of 6.2 EH/s and a peak BTC-equivalent hashrate of 6.4 EH/s.</li>
<li>Operational Efficiency: Achieved an average daily production rate of 3.2 BTC, equivalent to 16 BTC per Exahash.</li>
</ul>

HIVE

HIVE Digital Mined 89 BTC In February, Growing HODL Portfolio To 2,620 BTC Valued At $220M

Earlier this month, top executives from South Korea&#8217;s shipbuilding conglomerate Hyundai Heavy Industries Group and Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) met to push forward AI-driven shipyard innovation and future defense capabilities.
What Happened: HD Hyundai executive vice Chairman Chung Kisun visited Washington, D.C., to meet with Palantir CEO Alex Karp and discuss the companies&#8217; <a href="https://www.benzinga.com/news/22/09/28943372/palantir-hyundai-consolidate-partnership-expanding-into-shipbuilding">ongoing collaboration on building</a> an AI-powered shipyard.
The two leaders reviewed the progress of their &#8220;Future of Shipyard&#8221; (FOS) initiative, launched in 2021, and explored potential defense-related applications of artificial intelligence.
According to HD Hyundai, the companies agreed that AI-based defense solutions could play a pivotal role in national security strategies for both South Korea and the U.S.&nbsp;
Chung's visit comes as part of his U.S. tour to attend CERA Week, the major global energy conference taking place in Houston from March 10–14.
See Also: <a href="https://in.benzinga.com/government/regulations/25/03/44190445/palantir-delivers-ai-powered-battle-stations-to-us-army-stock-now-comparable-to-tesla-circa-2015-analyst">Palantir Delivers AI-Powered Battle Stations To US Army, Stock Now Comparable To Tesla Circa 2015: Analyst</a>
Why It's Important: The FOS project aims to complete the construction of an intelligent, autonomous shipyard by 2030, targeting a 30% boost in productivity and a 30% reduction in construction time.
In addition, the companies are co-developing an unmanned surface vessel (USV) named &#8220;TENEBRIS,&#8221; and collaborating through HD Hyundai Infracore.
This deepening partnership comes at a time of strong momentum for Palantir. Last month, the company reported <a href="https://in.benzinga.com/news/earnings/25/02/43449486/palantir-q4-earnings-revenue-beat-eps-beat-us-revenue-up-52-customer-count-up-43-strong-guidance-this-is-a-new-phase-unlike-anything-that-has-come-before">fourth-quarter revenue</a> of $827.52 million, beating analyst expectations of $775.91 million.&nbsp;
With this, Palantir has topped analyst projections for six consecutive quarters, with U.S. revenue rising 52% year-over-year. Its U.S. commercial business surged 64%, while government revenue increased 45%.
Meanwhile, on Sunday, VOA <a href="https://www.voanews.com/a/trump-pledges-to-resurrect-shipbuilding-as-china-seen-outpacing-us-/8004070.html">reported</a> that the U.S. Navy's fleet is shrinking despite efforts to expand, with more ships being decommissioned than built. Meanwhile, China's fleet is rapidly growing.
Major shipbuilders like BAE Systems and Huntington Ingalls Industries are operating below capacity due to inconsistent Navy contracts and budget delays. Meanwhile, President Donald Trump has vowed to create a new White House office to boost U.S. military and commercial shipbuilding.
Price Action: Palantir shares closed 5.52% higher at $84.90 on Friday but dipped 0.098% in after-hours trading, according to <a href="http://pro.benzinga.com/">Benzinga Pro</a>.
Image via Shutterstock
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44149586/credo-expands-hyperscaler-partnerships-with-amazon-microsoft-xai-amid-nvidia-powered-ai-boom" target="_blank" rel="noreferrer noopener">Analysts Highlight Credo Hyperscaler Partnerships With Amazon, Microsoft, xAI Amid AI Boom</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Tech

PLTR

Palantir CEO Alex Karp Meets Hyundai Vice Chair to Enhance AI Shipyard, Defense Collaboration Amid Trump's Call for US Shipbuilding Revival

Health Care

Press Releases

BioAtla Announces Upcoming Poster Presentation at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting

BioAtla Presented Phase 2 Ozuriftamab Vedotin Clinical Trial Data Demonstrating Meaningful Antitumor Activity with Manageable Tolerability among Heavily Pretreated Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody

BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress

BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting

BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024

Earnings

BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

Financing

BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points

CNTX

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Allakos

BioVie

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

Carisma Therapeutics, Inc. - Common Stock

CARISMA Therapeutics

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

CervoMed

GlycoMimetics

Geovax Labs

HCW Biologics

HOOKIPA Pharma

IN8bio

Longeveron

Leap Therapeutics

Lisata Therapeutics

MEI Pharma

Marker Therapeutics

Nanoviricides

NextCure

Palatin Techs

Senti Biosciences

Synlogic

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings)

Tenax Therapeutics

JMP Securities

JP Morgan

EF Hutton

BTIG

Credit Suisse

2008년 금융 위기 이전 주택 시장에 대한 선견지명 있는 투자로 유명한 유명 투자자 마이클 버리(Michael Burry)는 2024년 2분기에 자신의 헤지 펀드 포트폴리오에 큰 변화를 주었다.
어떤 일이 (What Happened): 사라토가에 본사를 두고 버리가 운영하는 사이언 에셋 매니지먼트(Scion Asset Management)는 수요일 미국 증권거래위원회(SEC)에 최신 13F 보고서를 제출하여 투자 전략의 주목할만한 변화를 밝혔다.
주요 포인트들은 다음과 같다:
<ol>
<li>알리바바 그룹 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)가 1위 자리를 차지함: 중국의 전자상거래 대기업인 알리바바는 155,000주로 구성된 약 1,116만 달러의 가치를 지닌 사이언의 최대 보유 기업이 되었다.</li>
<li>기술 초점: 이 포트폴리오는 중국 기술 기업들에 대한 지속적인 관심을 보여준다. 이에는 75,000주로 약 649만 달러의 가치를 형성하는 바이두(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>)와 25만 주로 646만 달러의 가치를 형성하는 징동닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>)의 큰 비중이 포함되어 있다.</li>
<li>헬스케어 및 핀테크: 몰리나 헬스케어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>)와 시프트4 페이먼츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>)는 각각 729만 달러와 734만 달러 상당의 상당한 투자를 보여준다.</li>
<li>부동산 노출: 허드슨 퍼시픽 프로퍼티즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPP#NYSE">HPP</a>)는 550만 달러 상당의 주식 110만 주를 보유한 중요한 부동산 회사로 두각을 나타낸다.</li>
<li>바이오테크 신생기업: 임상 단계의 바이오제약 회사인 바이오아틀라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>)는 포트폴리오에서 작지만 주목할만한 위치를 나타낸다.</li>
</ol>
기타 주목할만한 보유 자산으로는 더 리얼리얼(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAL#NASDAQ">REAL</a>), 올라플렉스 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLPX#NASDAQ">OLPX</a>), 그리고 아메리칸 코스탈 인슈어런스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>)가 있다.
중요성 (Why It Matters): 이 최신 서류는 버리의 현재 시장 전망에 대한 통찰력을 제공하며 중국 기술 기업, 미국 의료, 핀테크 및 엄선된 부동산 기회에 대한 상당한 투자를 통한 다양한 접근 방식을 제안한다.
지난 5월 버리는 <a href="https://www.benzinga.com/markets/asia/24/05/38878116/big-short-investor-michael-burry-bets-heavy-on-gold-renewable-energy-stocks-exits-amazon-alphabet">금 및 신재생 에너지</a>에 대한 막대한 투자로 헤드라인을 장식했으며 아마존닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) 및 알파벳(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)에서 포지션을 청산했다. 이 전환점은 실물 상품과 지속 가능한 에너지원에 초점을 맞추었음을 나타낸다.
관련해서, <a href="https://www.benzinga.com/general/entertainment/24/07/39695004/elon-musk-warren-buffett-nancy-pelosi-jensen-huang-michael-saylor-who-you-sitting-by-on-a-p">최근의 설문 조사</a>에서는 투자자들이 일론 머스크, 워런 버핏, Burry 자신과 같은 최고 인물들로부터 조언을 구하는 방법을 강조하여 투자 커뮤니티에서 그의 영향력을 강조한다.
Michael Burry illustration by Gonzalo Lanzilotta for
면책 조항: 본 콘텐츠는 인공지능 도구의 도움을 받아 제작되었으며, Benzinga 편집자들에 의해 검토되고 게시되었습니다.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

'빅쇼트' 명성의 마이클 버리, 중국에 큰 투자하고 알리바바를 최대 보유 주식으로 공개

Comments

BioAtla

뉴스

에 대한 최신 뉴스 BioAtla (NASDAQ:BCAB) 주식

목요일, 8월 15, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌